Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Opioid Hearing: Senators Want Speed, But Agency Heads Stress Time, Effort

Oct 05 2017

• By Michael Cipriano

Capitol House

Related Content

Lilly Shows Off R&D Progress With A Pain Franchise Built On New Mechanisms

May 30 2016

FDA's Opioid Programs: After Training, What's The Next Step?

Oct 05 2017

User Fee Bill Or Drug Pricing Bill? House Members Makes Both Cases

Jul 13 2017

Related Companies

Pfizer Inc.

Eli Lilly and Company

Additional Topics

United States Drug Safety Legislation Policy Neurology BioPharmaceutical

More from Drug Safety

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.